0.3333
-0.028 (-7.75%)
-0.028 (-7.75%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 2,271,147 |
|
|||||
| News | - | ||||||
| Day High | 0.361 | Low High |
|||||
| Day Low | 0.3283 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Timber Pharmaceuticals Inc | TMBR | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.028 | -7.75% | 0.3333 | 19:59:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3603 | 0.3283 | 0.361 | 0.333 | 0.3613 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,786 | 2,271,147 | $ 0.3415284 | $ 775,661 | - | 0.3283 - 3.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 1,081 | $ 0.333 | USD |
Period:
Draw Mode:
Timber Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 21.26M | 63.80M | 58.26M | $ - | $ - | -1.04 | 2.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 45.00k | 0.10% |
Timber Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMBR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3804 | 0.40 | 0.3283 | 0.3719286 | 654,522 | -0.0471 | -12.38% |
| 1 Month | 0.415 | 0.4549 | 0.3283 | 0.3976006 | 1,119,766 | -0.0817 | -19.69% |
| 3 Months | 0.7397 | 0.84 | 0.3283 | 0.51502 | 3,274,206 | -0.4064 | -54.94% |
| 6 Months | 1.15 | 1.17 | 0.3283 | 0.606546 | 1,914,563 | -0.8167 | -71.02% |
| 1 Year | 1.12 | 3.65 | 0.3283 | 1.78 | 3,678,149 | -0.7867 | -70.24% |
| 3 Years | 4.11 | 4.17 | 0.3283 | 1.68 | 2,835,226 | -3.78 | -91.89% |
| 5 Years | 4.11 | 4.17 | 0.3283 | 1.68 | 2,835,226 | -3.78 | -91.89% |
Timber Pharmaceuticals Description
| Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist). |